drugset / Trial / NCT00245453

Outpatient Registry Trial of Respiratory Tract Infections in Adults

NCT00245453

Phase 4 Withdrawn CPL Associates Sanofi · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

To measure the speed of bacterial eradication from the respiratory tract after administration of azithromycin or telithromycin.

Timeline

Start
2005-10
Primary completion
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azithromycin Small molecule 250 mg Oral
Comparator Clarythromycin Unknown 1000 mg Oral
Comparator Telithromycin Small molecule 800 mg Oral